Can walking and strength exercises help kids with advanced cancer?
NCT ID NCT03659968
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a personalized exercise program for children aged 5 to 17 with advanced cancer that cannot be cured. The program included walking on a treadmill and muscle-strengthening exercises, with the goal of seeing if it is safe and tolerable. Only 4 children took part, and the study focused on finding the right amount of exercise for each child based on their physical ability.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
4 people
The number who actually took part.
- Started
-
Jan 2019
- Finished
-
Jul 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
5 to 17 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients aged from 5 to 17 years old. * Cancer with no curative therapeutic options. * Stable disease (with or without treatment). * Ability to complete 100 meters walking without help and muscular strengthening exercises. * Written informed consent, including agreement of parents or legal guardian for minors. Exclusion Criteria: * Participation to another Phase I trial * Dyspnoea exertional * Cardio-vascular pathology * Life expectancy of less than 3 months * Progressive disease * Expected inability to comply to medical follow up
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pediatric cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assiatnce Publique Des Hopitaux de Marseille
Marseille, PACA, 13354, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can freezing ovarian tissue protect fertility in children facing cancer treatment?
- Tumor profiling may unlock targeted drug options for pediatric cancers
- Can a new pill tame childhood cancers that Won't quit?
- A bike ride could reveal hidden heart risks in young cancer survivors
- Can a new combo drug tame childhood leukemia that Won't quit?
- Can a Tumor's genetic blueprint guide better treatment for kids with brain cancer?